Thyroid Cell Differentiation from Murine Induced Pluripotent Stem Cells by Risheng Ma et al.
ORIGINAL RESEARCH




National Institutes of Health, USA
Reviewed by:
Sheue-Yann Cheng,
National Cancer Institute, USA
Tony Hollenberg,




Thyroid Research Unit, Department of
Medicine, James J. Peters Veterans
Affairs Medical Center, Icahn School
of Medicine at Mount Sinai, Room
2F-28, 130 West Kingsbridge Road,
New York, NY 10468, USA
risheng.ma@mssm.edu
Specialty section:
This article was submitted to Thyroid
Endocrinology, a section of the journal
Frontiers in Endocrinology
Received: 08 January 2015
Accepted: 06 April 2015
Published: 22 April 2015
Citation:
Ma R, Morshed SA, Latif R and
Davies TF (2015) Thyroid cell




Thyroid cell differentiation from
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Background: Here, we demonstrate the successful differentiation of induced pluripotent
stem (iPS) cells into functional thyroid cells indicating the therapeutic potential of this
approach when applied to individuals with thyroid deficiency.
Research design and methods: Using embryonic murine fibroblasts, we generated iPS
cells with a single lentiviral “stem cell cassette” vector and then differentiated these iPS
cells into thyroid cells after transfection with PAX8 and NKX2-1 by Activin A and TSH
stimulation.
Results: The generated iPS cells expressed pluripotent stem cell markers as assessed
using both reverse transcription quantitative PCRs and immunofluorescence staining with
~0.5% reprograming efficiency. Compared to control cells, the expression of thyroid-
specific genes NIS, TSHR, Tg, and TPO were greatly enhanced in PAX8+NKX2-1+ iPS
cells after differentiation. On stimulation with TSH, these differentiated iPS cells were
also capable of dose-dependent cAMP generation and radioiodine uptake indicative of
functional thyroid epithelial cells. Furthermore, the cells formed three-dimensional follicles
in culture, and “thyroid organoids” formed after PAX8+NKX2-1+ iPS cells transplanted
into nude mice, and all expressed Tg protein as judged immunohistochemically. Taken
together, thyroid epithelial cells differentiated from iPS cells, which were themselves
derived frommurine fibroblasts, exhibited very similar properties to thyroid cells previously
developed from traditional murine embryonic stem cells.
Conclusion: Thyroid cells differentiated from iPS cells offer the opportunity to examine the
detailed transcriptional regulation of thyroid cell differentiation and may provide a useful
future source for individualized regenerative cell therapy.
Keywords: induced pluripotent stem cells, thyroid differentiation, PAX8, NKX2-1, TSH receptor
Introduction
Thyroid deficiency, as an irreversible change, occurs due to autoimmune disease (Hashimoto’s
thyroiditis), radioiodine therapy, and thyroid surgery. Although themajority of hypothyroid patients
feel well on thyroid hormone replacement therapy, there remains a small proportion claiming not to
feel normal. An improved treatment strategy for these patients is still needed. Although differenti-
ated human pluripotent embryonic stem (ES) cells are the ideal seed cells for transplantation, ethical
issues regarding their source and potential immunological barriers have restricted their application
in cell therapy. With the advances in stem cell biology and the recent discovery that somatic
mammalian cells can be epigenetically reprogramed to a pluripotent state through the exogenous
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expression of the four transcription factors – “yamanaka factors” –
has opened up the field of personalized regenerative medicine
(1, 2). The expression of these four defined factors – OCT3/4,
SOX2, KLF4, cMYC – into an adult somatic cell has the abil-
ity to dedifferentiate it into an embryonic cell with potential of
developing into any cell lineages under appropriate environmental
cues. Thus, IPSC holds great promise as an unlimited source for
individualized cell replacement therapy (1) without the ethical or
practical concerns associated with ES cells (3). Nevertheless, there
remain technical issues with this technology due to lack of full
understanding of the epigenetic changes during the reprogram-
ing process and the challenge of optimizing the reprograming
efficiency within each tissue type (4).
We, and others, have recently described the induction of thyroid
follicular cell differentiation from human and mouse ES cells by
over-expression of the thyroid transcription factors PAX8 and
NKX2-1 (5–7). In the present study, we generatedmurine induced
pluripotent stem (iPS) cells using a single lentiviral “stem cell
cassette” (STEMCCA) vector and fully characterized them prior
to over-expression of the two critical transcription factors – PAX8
and NKX2-1. Further, these double transfected cells, as described
previously (5), were induced to form endoderm-derived embryoid
bodies (EBs) and finally differentiated into thyroid follicles. Our
results indicate that the thyroid cells generated from iPS cells
exhibited identical properties to those cells derived from ES cells
confirming that iPS cells may be useful source for cell therapy
and also as a tool for deriving patient-specific human cell lines for
studying thyroid cell biology.
Materials and Methods
Generation and Maintenance of Mouse Induced
Pluripotent Stem Cell
Mouse iPS cells were generated by reprograming mouse embry-
onic fibroblasts (MEFs) (originally derived from the Swiss Web-
ster mouse and supplied by the Pluripotent Stem Cell Shared
Resource Facility at Mount Sinai) using a single lentiviral vector,
expressing a “stem cell cassette” composed of the four transcrip-
tion factors, Oct4, Klf4, Sox2, and cMyc from a single multi-
cistronic transcript (8). About 100,000 fibroblasts/well were plated
into 0.1% gelatin-coated 6-well plates and infected with 15 µl of
concentrated virus in the presence of polybrene (5 µg/ml) after
the cells had attached. After 16 h, the medium was replaced with
mouse ES cell culture medium [DMEM supplemented with 15%
FBS, -glutamine, penicillin/streptomycin, non-essential amino
acids, β-mercaptoethanol, and 1,000U/ml leukemia inhibitory
factor (LIF)] and changed every other day. iPS colonies were
picked 15–20 days post-infection on the basis of morphology and
expanded by plating on irradiation-treatedMEFs in ES cell culture
medium. After one to two passages, iPS cells were directly adapted
to feeder-free culture conditions.
Generation of PAX8, or NKX2-1, or
PAX8+NKX2-1 Expressing iPS Cell Lines
Two vectors, M48EF1αPAX8IVREShyg and M48EF1αNKX2-
1IVRESneo, were kindly provided by Dr. Uwe Haberkorn of
the German Cancer Research Center, Heidelberg, Germany (8).
These vectors, alone or together, were electroporated into iPS cells
(Neon transfection system, Life technologies) and after 2 days,
the cells were cultured in either hygromycin (0.5mg/ml) or G418
(0.8mg/ml), or both for at least 4 weeks until resistant clones were
established. Stable clones were then selected and characterized for
their gene expression and for further differentiation.
Differentiation of iPS Cells
Embryoid bodies were differentiated as described previously (9).
In brief, single ES cell suspensions were plated in ultralow attach-
ment dishes (Costar 3471, Corning Inc., NY, USA) to induce EB
formation in the absence of LIF. EBs were cultured for 1 day in the
same culture medium as ES cells except for the lack of LIF. The
following day, EBs were harvested and allowed to settle by gravity
in a 50-ml tube and transferred to new dishes and cultured in fresh
medium supplemented with or without 50 ng/ml human Activin
A (R&D Systems, Inc.) for 5 days. To induce the differentiation
of iPS cells into thyroid cells, EBs were collected and embedded
in growth factor-restricted Matrigel (BD Biosciences) and placed
into six-well plates in differentiation medium that contained
DMEM supplemented with penicillin/streptomycin, 15% Knock-
Out serum replacement medium (Invitrogen Life Technologies),
5% protein-free hybridoma medium (PFHM-II; Invitrogen Life
Technologies), 1.5 10 4M monothioglycerol, and 1,000 µU/ml
human recombinant TSH (Fitzgerald Industries, Concord, MA,
USA) for another 16 days. Cells were harvested for analysis at days
5 and 21 (total time) of culture.
Gene Expression Analysis
For gene expression analysis, total RNA was extracted using
RNeasy (Qiagen Ltd.) and treated with ribonuclease-free deoxyri-
bonuclease (Qiagen). Five micrograms of total RNA were reverse
transcribed into cDNA using the SuperScript III system (Invit-
rogen). Real-time quantitative RT-PCR (qRT-PCR) was carried
out using SYBR green qPCR master mix (Applied Biosystems)
employing the StepOnePlus system (Applied Biosystems). Rel-
ative expression levels of each gene in real-time were analyzed
using the 2 ∆∆CT method and normalized to the expression of
the housekeeping gene GAPDH. Data presented (mean) are from
three independent experiments in which all sample sets were
analyzed in triplicate.
Immunofluorescence Staining
Cells were grown in Delta T culture dishes and fixed with 4%
paraformaldehyde in phosphate-buffered saline (PBS) and rinsed
three times with PBS. After being permeabilized in methanol
at  20°C for 10min, the cells were blocked for 60min with
5% normal goat serum in PBS. Cells were then incubated with
appropriate primary antibodies in 0.1% Tween 20 and 1% BSA in
PBS overnight at 4°C. Cells were rinsed three times with PBS and
incubated with the appropriate secondary antibody. Then cells
were rinsed three times with PBS, and mounted using hard set
mounting media containing DAPI (Vector Laboratories). Fluo-
rescence micrographs were acquired using a LSM 700 confocal
microscope with a 63 objective, and images were processed and
assembled in Photoshop CS (Adobe, San Jose, CA, USA).
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TSHR Functional Assessment
Intracellular cAMP generation was measured with a cAMP
enzyme immunoassay kit (GE Healthcare Bio-Sciences). Briefly,
the differentiated iPS cells were seeded in a 24-well tissue culture
plate at a density of ~1.0 105 cells/dish in 1ml medium 24 h
prior to the experiment. The cells were then stimulated with
increasing concentrations of TSH for 1 h. The medium was aspi-
rated, the cells washed with fresh PBS and lysed for 10min. A total
of 100 µl of each sample was transferred into the appropriate well
of the immunoassay microtiter plate and intracellular cAMP was
measured as described by the manufacturer.
Radioactive Iodine Uptake
The differentiated iPS cells were seeded in a 24-well plate at
a density of ~1.0 105 cells/well for 24–48 h. Cells were then
washed with modified Hanks’ balanced salt solution, then incu-
bated in the same buffer containing 20 µM sodium iodide supple-
mented with 10 µCi carrier-free Na125I to give a specific activity
of 10 µCi/mmol for 45min at 37°C in a humidified atmosphere.
Parallel wells of cells were incubated in the absence or presence
of TSH and/or perchlorate. Aspirating the radioactive solution
and washing twice with ice-cold Hanks’ balanced salt solution
terminated the uptake reactions. To determine the amount of 125I-
accumulated in the cells, 95% ethanol was added to each well
for 20min at 4°C, then quantitated in a γ-counter, as previously
described (10). 125I-uptake was expressed as cpm per well per
45min. The values represent themean SEMof two independent
experiments performed in triplicate.
Thyroid Follicle Formation In vivo
Five-week-old nude male mice (The Jackson Laboratory) were
housed in pathogen-free conditions with the approval of the
Institutional Animal Care and Use Committee of Mount Sinai
School ofMedicine. The EB cells derived from transfected iPS cells
were re-suspended in Matrigel-PBS and injected subcutaneously.
The injected Matrigel-cells rapidly formed a solid structure. After
3–4weeks, the formed structure were surgically excised from the
mice without connective tissues and embedded into paraffin and
sectioned for immunohistochemistry.
Results
Generation and Characterization of Induced
Pluripotent Stem Cells
Induced pluripotent stem cells were derived from MEFs infected
with the EF1a-STEMCCA Polycistronic (OKSM) Lentivirus (8).
MEFs, reprogramed with the constitutive EF1a STEMCCA con-
struct, showed a dramatic change in morphology already evi-
dent 6 days post-infection and formed colonies that displayed
the typical morphology of ES cell colonies (Figure 1A). Control
FIGURE 1 |Mouse iPS cells have cell morphology and staining
characteristics of mouse ES cells. (A) MEFs formed multilayered, tightly
packed cells with well-defined borders after infection with the STEMCCA
Lentivirus. This figure shows a representative phase contrast image of a
single mouse iPS cell colony taken at 12 days post-infection.
Scale= 200 µm. (B) Control well of MEFs not infected with the STEMCCA
Lentivirus. Cells remain in a monolayer culture with no ES cell-like colonies
observed. This is a representative phase contrast image taken at the same
time point as that in (A). Scale= 200 µm. (C) Embryoid bodies formed from
iPS cells derived from MEFs. Scale= 200 µm. (D) Expression of ES cell
marker genes detected by RT-PCR in iPS cells generated using the
STEMCCA vector. (E–G) Representative immunostaining Sox2 (E), SSEA-1
(F), and Nanog (G) in the derived iPS cells. Scale= 100 µm. Abbreviations:
N, negative control; MEF, mouse embryonic fibroblast; ES, mouse
embryonic stem; iPS, induced pluripotent stem; SSEA-1, stage-specific
embryonic antigen 1.
Frontiers in Endocrinology | www.frontiersin.org April 2015 | Volume 6 | Article 563
Ma et al. Thyroid cells and iPS cells
MEFs that had not been infected with the STEMCCA Lentivirus
remained in a monolayer culture with no ES cell-like colonies
observed (Figure 1B). The effective reprograming efficiency was
~0.5%, about 10-fold higher than that observed in prior reports
(0.01–0.05%) (11, 12). The generated iPS cells were then able to
spontaneously form EBs (Figure 1C). The molecular signature of
the iPS cells was validated by RT-PCR and as expected showed
expression of a variety of classical ES cell markers such as Oct4,
Sox2, Nanog, and REX1, whereas, these genes were not expressed
in the fibroblasts prior to reprograming (Figure 1D). Expression
of ES cell markers including Sox2, SSAE-1, and Nanog are also
illustrated using immunostaining (see Figures 1E–G). These data
confirmed successful iPS reprograming from the MEF cells.
Establishment of PAX8, NKX2-1, PAX8+NKX2-1+
iPS Cell Lines
We have shown in previous studies that thyroid follicular cells
can be generated from mouse ES cells by co-expressing thyroid
transcription factors PAX8 and NKX2-1 and culturing the cells
in the presence of activin A and TSH (5, 6). The generated iPS
cells were, therefore, electroporated with the PAX8 and/or NKX2-
1 vectors and selected with specific antibiotic to establish stable
iPS cell lines (5). As evidenced by RT-PCR analysis, PAX8+ cells
expressed high levels of PAX8, NKX2-1+ cells expressed high lev-
els of NKX2-1, while, PAX8+NKX2-1+ cells expressed high levels
of both PAX8 and NKX2-1 and FOXE1 expression was induced
(Figure 2A). This was further confirmed by immunodetection
of Pax8 and NKx2-1 nuclear expression in individual cell lines
(Figures 2B–D). However, over-expression of these transcription
factors at this stage did not change the pluripotent state of the iPS
cells since they continued to express a variety of stem cell genes
(Figure 2E). Although these iPS cell lines expressed a limited
degree of thyroid-specific genes (TSHR, NIS, and Tg), Tg protein
was not detected indicating that while co-expression of PAX8 and
NKX2-1 in untreated iPS stable lines initiated a change in the cell’s
fate, driving their differentiation toward a thyroid follicular cell
lineage, the degree of differentiation was insufficient for thyrocyte
fate determination.
Differentiation of PAX8+NKX2-1+ iPS Cells into
Thyroid Cells
Individual iPS cells expressing PAX8, NKX2-1, or both factors
were successfully differentiated into thyroid cells by Activin A
and TSH as previously found for similar ES-derived cells (5).
Since Activin A can induce endoderm differentiation (9), we
cultured the double transfected cells in ultralow attachment dishes
to encourage embryoid body formations (EBs) and treated these
cells with Activin A for 5 days, resulting in the induction of
endoderm markers Sox17, Fox2, and AFP (Figure 3A). These
Activin A treated cells demonstrated upregulation of TSHR gene
expression but no further induction of Tg transcription (5, 9).
However, after further differentiation with TSH, thyroid-specific
FIGURE 2 | Characterization of PAX8, NKX2-1, and Pax8+NKx2-1+
mouse iPS cell lines. (A) RT-PCR analysis of selected iPS cell lines for
thyroid transcription factors. The figure shows PAX8, NKX2-1, and FOXE1
transcription after culture in selection medium for up to 4weeks. Data
presented (mean) are from three independent experiments in which all sample
sets were analyzed in triplicate. **p<0.01 compared to untransfected iPS
cells. (B–D) Immunofluorescence analysis of PAX8 and NKX2-1 in the
transfected cell lines. Scale= 100 µm. (E) Retention of stemness in
transfected cell lines is shown by the continued expression of Oct4, Sox2,
Nanog, and Rex1 gene expression.
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FIGURE 3 | The differentiation of iPS cells into thyroid cells.
(A) Representative RT-PCR analysis for the expression of endoderm
markers, Sox17, Fox2, and AFP, in Activin A (AA) treated and untreated
cells. Data were expressed as meanSEM and represent one of three
separate experiments. (B) Thyroid-specific genes (Tg, TPO, TSHR, and NIS)
in individual cell lines after differentiation with Activin A and TSH. Data were
expressed as meanSEM and represent one of three separate
experiments. The difference between control ES cells, Pax8+, Nkx2-1+ and
double positive cells was highly significant (p<0.01) for each of the mRNA
examined. (C,D) Immunostaining of thyroid neofillicles derived from double
transfected PAX8+NKX2-1+ iPS cells after differentiation with Activin A and
TSH and showing TSHR expression (red) on the cell surface (C) and Tg
expression (green) in the follicle lumen and cytoplasm (D). Scale
bar=100 µm.
genes (NIS, TSHR, Tg, and TPO) were all better expressed in
Pax8+NKX2-1+ iPS cells in comparison with single transfected
iPS cell lines, as evidenced by qPCR analysis (Figure 3B). These
differentiated double transfected cells formed three-dimensional
thyroid follicle withwidespreadTSHRexpression (Figure 3C) and
Tg expression (Figure 3D), evidencing these cells as committed to
their thyrocyte fate.We estimate that ~50% of cells formed thyroid
follicles in these experiments.
Functionality of Differentiated Thyroid Cells
The double transfected and differentiated iPS cells were further
analyzed by assessment of TSH stimulated cAMP generation
(Figure 4A). A dose-dependent cAMP response to TSH was
observed with a sensitivity of 10 µU/ml; similar to the rat thy-
roid cell control. No response was seen in the control ES cells.
These differentiated thyroid cells, maintained under steady-state
conditions without TSH (as described in Section “Materials and
Methods”), also demonstrated significantly increased 125I uptake
in response to TSH which was inhibited by sodium perchlorate
acting as a NIS inhibitor (Figure 4B).
Differentiation of PAX8/NKX2-1 iPS Cells into
Thyroid Cells In vivo
To assess the potential thyroid differentiation of iPS cells
in vivo, the PAX8+NKX2-1+ iPS EB cells, following Activin A
exposure for 5 days, were injected subcutaneously into 5-week-
old nude mice. Histological analysis 4 weeks after transplanta-
tion demonstrated the formation of thyroid tissue in the host
mice (Figure 5A) with Tg deposition in the follicular lumens
(Figure 5B).
Discussion
The exact mechanism of successful thyroid cell differentiation
from stem cells is far from clear. It has previously been reported
that murine and human ES cells can be induced to differentiate
into functional thyroid follicles by the combined expression of
Pax8 and Nkx2-1 using transfection or direct induction (5, 6).
Here, we aimed to determine whether murine iPS cells would
behave in a similar manner. We found that after differentiation
withActivinA andTSH, Pax8+Nkx2-1+ expressing iPS cells were
indeed induced to thyroid follicular cells in a similar manner to
ES cells as evidenced by the expression of thyroid-specific genes
and the formation of thyroid follicular-like structures in vitro
and in vivo. iPS cells may, therefore, be an ideal source for cell
replacement therapy when derived from hypothyroid patients.
We generated iPS cells from embryonic fibroblasts using a sin-
gle lentiviral “stem cell cassette” (STEMCCA) vector, expressing
the four transcription factors, Oct4, Klf4, Sox2, and cMyc, from
a single multicistronic transcript which was highly efficient (8).
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FIGURE 4 | Functionality of differentiated thyroid iPS cells.
(A) Differentiated Pax8+NKX2-1+ iPS cells demonstrated cAMP generation in
response to increasing concentrations of TSH. The sensitivity of rat thyroid cells
(FRTL-5) is illustrated for comparison within the same experiment.
(B) Differentiated Pax8+NKX2-1+ iPS cells were exposed to 125 I (as described
in Section “Materials and Methods”) and the radioactive iodine uptake into the
differentiated thyroid cells was measured with and without TSH. Specificity was
shown by the use of sodium perchlorate to inhibit the action of NIS and prevent
radioactive iodine uptake. The insert is the radioactive iodine uptake in rat
thyroid cells, FRTL-5 cell.
FIGURE 5 | The formation of thyroid follicles in vivo. (A) The histological
analysis of Pax8+NKX2-1+ iPS cells grafted subcutaneously into nude mice
after 4weeks (H&E) showing follicle formation. (B) Immunostaining for Tg in
the grafted tissue showed Tg deposition in the luminal compartment. Scale
bar= 20 µm.
These iPS cells were clearly pluripotent as shown by a number of
accepted criteria such as their morphology and stem cell marker
expression. iPS cells derived from mouse (11, 12) or human (1,
13) fibroblasts have been well demonstrated to offer the potential
to replace many organs using readily accessible postnatal somatic
cells and the use of a single lentiviral STEMCCA vector for the
induction of iPS cells enabled high efficiency of reprograming
and limited numbers of viral integrations, which is in marked
contrast to previous reports using multiple vectors requiring>15
viral integrations (1, 12). Since the original discovery of iPS cells,
there has been great progress in iPS cell research in improving
both the efficiency and safety of the reprograming steps (14)
and also in the differentiation of iPS cells for the treatment of
several conditions (12, 15). However, the generation of patient-
specific iPS cells is still a technical and time demanding procedure
and long-term problems, such as cancer formation, are unlikely
to be circumvented by this transfection approach. Direct chem-
ical reprograming, therefore, is in need of further exploration
(16). Epigenetic changes during the reprograming process have
shown considerable differences between iPS and ES cells and this
must also be addressed before iPS cell technology can be utilized
therapeutically.
Tissue-specific transcription factors play a vital role in estab-
lishing cell identity during development. Tissue-specific gene
expression reflects the coordinated activities of transcription fac-
tors that are restricted to one or a few cell types. Several thyroid-
specific transcription factors have been identified and character-
ized, including Pax8, NKX2-1, Foxe1, and Hex (17, 18). Each
of these factors controls the maintenance of the expression of
others. For example, the simultaneous presence of Pax8, Nkx2-1,
and Hex are required for the expression of Foxe1 (19, 20) and in
this study, the expression of Foxe1 was also significantly induced
in Pax8+Nkx2-1+ double transfected iPS cells in comparison to
the control and single transfected iPS cells. These transcription
factors have a central function in other embryonic tissues, but
it is only in the endoderm cells committed to a thyroid cell fate
that the combination of all four can be found. While HEX and
FOXE1 are expressed throughout the endoderm, NKX2-1 and
PAX8 expression is restricted to the thyroid placode indicating
their crucial role in thyroid cell speciation. Here, we demon-
strated that fibroblast derived iPS cells could also be induced
to differentiate into thyroid follicular cells by over expressing
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Pax8 and Nkx2-1 in a similar manner to mouse ES cells with an
efficiency approaching 50% of cells.
In summary, we showed the differentiation of mouse iPS
cells into thyroid follicular cells via over-expression of PAX8
and NKX2-1 and induction with Activin A and TSH. These
differentiated PAX8+NKX2-1+ expressing iPS cells expressed
thyroid-specific genes and proteins, formed three-dimensional
follicles when cultured with an extracellular matrix and formed
Tg expressing thyroid follicles after transplantation into nude
mice. This study demonstrates the potential for generation of
patient-specific thyroid stem cells, which can be used for regen-
erative medicine and also lead to the generation of patient-
specific cell lines that can potentially be used to model thyroid
diseases and ultimately act as substrate for testing new therapeutic
agents.
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